Colinz Laboratories Ltd

BSE: 531210
Colinz Laboratories Ltd - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN L24200MH1986PLC041128 Incorporated 06 October 1986 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - BSE: 531210 Public Limited Company pharma
Data last updated
Market Cap
₹18.52 Cr
COLINZ · BSE
Share Price
₹73.50
-4.16% today
Revenue
₹6.14 Cr
FY 2025-26 · -4.8% YoY
EBITDA
₹0.39 Cr
Margin 6.3%
Net Profit
₹0.49 Cr
FY 2025-26 · +2.1% YoY
P/E (TTM)
19.0x
P/B 1.1x
ROE
5.2%
ROCE 7.1%
Debt / Equity
0.05
Interest cover 21.7x

About Colinz Laboratories Ltd

Data last updated:

Colinz Laboratories Ltd is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 October 1986 and has been in existence for over 40 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24200MH1986PLC041128. Its GSTIN is 27AAACC7277L1Z8 (Maharashtra). Its shares are listed on BSE: 531210.

The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹2.52 Cr. It was formerly known as Colinz Laboratories Private Limited. It is led by directors including Narayanan Kutty Menon (Whole-Time Director) and Baptist Bernard Dias.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A 101 Pratik Ind Estatemulund Goregaon Link Road Bhandup West, Mumbai, Maharashtra, India – 400078.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹6.14 Cr, a decline of 5.97% compared to the previous year. The net worth stands at ₹10.04 Cr (up 5.91% YoY). Total assets are valued at ₹10.43 Cr (up 3.06% YoY).

The company has about 29 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Colinz Laboratories. As per MCA filings, the company has satisfied charges of ₹1.98 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website colinz.com.

Company Details of Colinz Laboratories Ltd
CIN L24200MH1986PLC041128
Registration Number 041128
Incorporation Date 06 October 1986
ROC Mumbai
Listing Status Listed (BSE: 531210)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Narayanan Kutty Menon Whole-Time Director Vijaya Mani Additional Director Baptist Bernard Dias Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    colinz.com
  • Social Media
  • Registered Address
    A 101 Pratik Ind Estatemulund Goregaon Link Road Bhandup West, Mumbai, Maharashtra, India – 400078
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Colinz Laboratories Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Colinz Laboratories Ltd report

Financials, compliance, directors, charges, ownership and filings for Colinz Laboratories Ltd in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Colinz Laboratories

Colinz Laboratories operates one associated brand: Colinz Laboratories. Each brand links to its own profile.

BrandDescriptionWebsite
Colinz Laboratories
Pharmaceutical formulations in allopathic, ayurvedic, and nutraceutical forms are manufactured.colinz.com

Business Activity of Colinz Laboratories

The main business activity of Colinz Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details for Colinz Laboratories Ltd

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Colinz Laboratories

Colinz Laboratories Ltd is audited by VORA & ASSOCIATES for the financial year 2022.

NameStatusAppointment DateCessation Date
VORA & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history for Colinz Laboratories Ltd

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Colinz Laboratories Ltd

Colinz Laboratories has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Narayanan Kutty Menon
Also directs: Alvaro Healthcare Private Limited
Whole-Time Director01 Oct 200422 Years 0 MonthsCurrent
Vijaya Mani
Also directs: Bueno Healthcare Private Limited
Additional Director11 Nov 20250 Years 10 MonthsCurrent
Baptist Bernard DiasDirector08 Aug 20242 Years 1 MonthsCurrent
Bhavik Ashokkumar Shah
Also directs: Omnitex Industries (India) Limited, Gaekwar Mills Limited, MSL Global Limited and 2 more
Director08 Aug 20242 Years 1 MonthsCurrent
View all directors

Financials of Colinz Laboratories Ltd FY 2025-26 filings available

Colinz Laboratories Ltd reported revenue of ₹6.14 Cr (down 5.97% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹6.14 Cr
-6.0% YoY
EBITDA
₹0.39 Cr
-20.4% YoY
Profit After Tax
₹0.49 Cr
+2.1% YoY
Net Worth
₹10.04 Cr
+5.9% YoY
Total Assets
₹10.43 Cr
+3.1% YoY
Total Debt
₹0.39 Cr
-39.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue6.146.537.037.156.976.167.53
Revenue growth-4.8%-6.8%-1.2%+2.8%+9.3%-19.2%-0.1%
EBITDA0.390.490.550.590.590.320.30
EBITDA margin+6.4%+7.5%+7.8%+8.3%+8.5%+5.2%+4.0%
Profit before tax0.660.620.660.580.480.230.17
Net profit0.490.480.490.460.340.190.12
Net profit margin+8.0%+7.4%+7.0%+6.4%+4.9%+3.1%+1.6%
EPS (₹)2.041.971.931.820.960.590.37
Balance sheet
Total assets10.4310.129.528.418.218.287.32
Net worth10.049.488.958.147.697.306.83
Total debt0.390.640.570.270.480.990.38
Cash & bank8.535.557.005.735.214.682.60
Net working capital7.907.497.136.225.895.694.61
Cash flow
Cash from operations2.54(1.45)1.030.400.472.160.58
Cash from investing0.01(0.23)0.010.01(0.03)(0.16)(0.04)
Cash from financing0.430.240.230.110.090.080.06
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue1.241.751.431.391.571.451.471.86
Revenue growth (YoY)-21.0%+20.7%-2.7%-25.3%-10.3%-11.0%-14.0%+3.9%
Other income2.890.170.080.160.080.080.080.08
Total expenses1.181.661.331.311.431.351.401.69
EBITDA0.060.090.100.080.140.100.070.17
EBITDA margin+4.8%+5.1%+7.0%+5.8%+8.9%+6.9%+4.8%+9.1%
Depreciation0.040.040.040.040.040.030.030.03
Interest0.010.010.010.010.010.020.010.01
Profit before tax2.900.210.130.190.170.130.110.21
Tax0.500.040.040.050.04(0.03)0.050.05

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 04 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue1.241.751.431.391.571.451.471.86
Revenue growth (YoY)-21.0%+20.7%-2.7%-25.3%-10.3%-11.0%-14.0%+3.9%
Other income2.890.170.080.160.080.080.080.08
Total expenses1.181.661.331.311.431.351.401.69
EBITDA0.060.090.100.080.140.100.070.17
EBITDA margin+4.8%+5.1%+7.0%+5.8%+8.9%+6.9%+4.8%+9.1%
Depreciation0.040.040.040.040.040.030.030.03
Interest0.010.010.010.010.010.020.010.01
Profit before tax2.900.210.130.190.170.130.110.21
Tax0.500.040.040.050.04(0.03)0.050.05
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue6.146.537.037.156.976.167.53
Revenue growth-4.8%-6.8%-1.2%+2.8%+9.3%-19.2%-0.1%
Other income0.480.300.280.170.170.190.13
Total expenses5.756.046.486.566.385.847.23
Employee cost2.532.672.792.902.772.393.25
EBITDA0.390.490.550.590.590.320.30
EBITDA margin+6.4%+7.5%+7.8%+8.3%+8.5%+5.2%+4.0%
Depreciation0.160.130.130.130.200.190.19
Interest0.050.040.040.050.080.090.07
Profit before tax0.660.620.660.580.480.230.17
Tax0.170.130.170.140.140.040.05
Net profit0.490.480.490.460.340.190.12
Net profit margin+8.0%+7.4%+7.0%+6.4%+4.9%+3.1%+1.6%
EPS (₹)2.041.971.931.820.960.590.37
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital2.522.522.522.523.553.553.54
Reserves & surplus7.526.966.435.624.143.753.29
Shareholders' funds (net worth)10.049.488.958.147.697.306.83
Secured loans0.000.000.000.000.000.000.38
Unsecured loans0.390.640.570.270.480.990.00
Total debt0.390.640.570.270.480.990.38
Total liabilities10.4310.129.528.418.218.287.32
Assets
Gross block6.436.436.176.176.916.886.72
Net block1.541.701.571.711.862.032.06
Capital work in progress0.000.000.000.000.000.000.00
Investments1.111.041.020.660.670.610.36
Inventories0.700.780.850.940.931.251.69
Sundry debtors0.840.660.861.131.211.301.49
Cash & bank balances8.535.557.005.735.214.682.60
Loans & advances0.012.020.030.030.040.050.06
Total current assets10.089.018.747.837.397.285.84
Total current liabilities2.181.521.611.611.501.591.23
Net working capital7.907.497.136.225.895.694.61
Total assets10.4310.129.528.418.218.287.32
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash5.557.005.735.214.682.611.99
Net cash from operating activities2.54(1.45)1.030.400.472.160.58
Net cash from investing activities0.01(0.23)0.010.01(0.03)(0.16)(0.04)
Net cash from financing activities0.430.240.230.110.090.080.06
Net change in cash2.98(1.45)1.270.520.522.070.60
Closing cash8.535.557.005.735.214.682.60
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-6.0%-7.1%-1.7%+2.6%+13.2%-18.2%-0.8%
EBITDA growth-20.4%-10.9%-6.8%0.0%+84.4%+6.7%-14.3%
PBT growth+6.5%-6.1%+13.8%+20.8%+108.7%+35.3%+13.3%
Net income growth+2.1%-2.0%+6.5%+35.3%+79.0%+58.3%+9.1%
Revenue CAGR (3Y)-5.0%-2.2%+4.5%-1.7%-2.8%-7.7%-2.2%
EBITDA CAGR (3Y)-12.9%-6.0%+19.8%+25.3%+19.0%-4.7%-9.9%
Profitability & leverage
Net income margin+8.0%+7.5%+7.0%+6.2%+4.9%+3.1%+1.6%
Return on capital employed+7.1%+6.7%+7.7%+7.8%+6.8%+4.4%+3.3%
Return on net worth+5.2%+5.4%+5.7%+5.8%+4.5%+3.0%+1.9%
Debt / equity0.050.070.050.050.100.100.08
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover21.7411.119.5210.8720.5169.2363.64
Efficiency & per share
Fixed asset turnover0.951.041.141.091.010.911.14
Inventory turnover8.308.017.857.656.394.194.23
Debtors turnover8.198.597.076.115.554.424.79
EPS (₹)2.041.971.931.820.960.590.37
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)39.8737.6135.5232.3121.6920.5719.29
Want more history and ratios?
You're viewing the latest exchange-filed financials for Colinz Laboratories Ltd. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Colinz Laboratories Ltd

Shareholding for the quarter ended Mar 2026: promoters hold 66.00%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 34.00%.

Promoters: 66.00%Retail & Others: 34.00%
Mar 2026
QUARTER
66.00% Promoters
34.00% Retail & Others
Promoter holding - history
Now 66.00% · Mar 2026High 66.00% · Jun 2025Low 66.00% · Jun 2025
65%65.5%66%66.5%67%Jun 2025Sep 2025Dec 2025Mar 2026Jun 2025: 66.00%Sep 2025: 66.00%Dec 2025: 66.00%Mar 2026: 66.00%66.00%66.00%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025
Promoters66.00%66.00%66.00%66.00%
Public34.00%34.00%34.00%34.00%

Charges & Borrowings of Colinz Laboratories

Open charges
None
Satisfied charges
₹1.98 Cr
Breakdown by lending institutions
Bank of Baroda₹1.98 Cr
Latest charge details
DateLenderAmountStatus
01 Mar 1999Bank of Baroda₹1.15 CrSatisfied
15 Oct 1998Bank of Baroda₹13.22 LakhSatisfied
25 Aug 1994Bank of Baroda₹39 LakhSatisfied
15 Jan 1993Bank of Baroda₹19.8 LakhSatisfied
19 Aug 1987Bank of Baroda₹11.4 LakhSatisfied

Total charge records: 5 View all charges

Employees and EPFO Compliance at Colinz Laboratories

Colinz Laboratories Ltd has a workforce of 29 employees as of Mar 23, 2024.

Employee count
29
Active EPFO establishments
1
Employee growth
7.41%
Premium access

Employee and EPFO history for Colinz Laboratories Ltd

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Colinz Laboratories

Colinz Laboratories has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACC7277L1Z8MaharashtraActive01 Jul 2017
Premium access

GST registrations and filing compliance for Colinz Laboratories Ltd

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Colinz Laboratories

Premium access

Credit ratings, litigation, and regulatory alerts for Colinz Laboratories Ltd

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Colinz Laboratories

Premium access

MSME payment history for Colinz Laboratories Ltd

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Colinz Laboratories

Premium access

Corporate group structure for Colinz Laboratories Ltd

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Colinz Laboratories

Premium access

MCA filings and documents for Colinz Laboratories Ltd

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Colinz Laboratories

Directors
18 Dec 2025
Falguni Kumawat was appointed as a Company Secretary on 18 Dec 2025 & has been associated with this company since 9 months 18 days.
Directors
11 Nov 2025
Vijaya Mani was appointed as a Additional Director on 11 Nov 2025 & has been associated with this company since 10 months 24 days.
Activity
30 Sep 2025
Colinz Laboratories Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Colinz Laboratories Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Directors
08 Aug 2024
Baptist Bernard Dias was appointed as a Director on 08 Aug 2024 & has been associated with this company since 2 years 1 month.
Directors
08 Aug 2024
Bhavik Ashokkumar Shah was appointed as a Director on 08 Aug 2024 & has been associated with this company since 2 years 1 month.

Recent News on Colinz Laboratories

Frequently Asked Questions about Colinz Laboratories Ltd

Colinz Laboratories is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 October 1986 (40+ years old) and is registered under CIN L24200MH1986PLC041128. Listed on BSE: 531210.

Colinz Laboratories reported revenue of ₹6.14 Cr for FY 2025-26 (down 5.97% YoY) based on standalone financials.

Colinz Laboratories has 4 current directors:

The GSTIN of Colinz Laboratories is 27AAACC7277L1Z8, registered in Maharashtra.

The CIN (Corporate Identification Number) of Colinz Laboratories is L24200MH1986PLC041128. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Colinz Laboratories is listed on BSE with code 531210.

Colinz Laboratories was incorporated on 06 October 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.

Colinz Laboratories can be reached through the website colinz.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Colinz Laboratories is at A 101 Pratik Ind Estatemulund Goregaon Link Road Bhandup West, Mumbai, Maharashtra, India – 400078.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available